Back
Candel Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
11
CADL
Candel Therapeutics, Inc.
Last Price:
$5.25
Seasonality Move:
-19.31%
7 Day Trial
ALL ACCESS PASS
$
7
Candel Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Candel Therapeutics, Inc. has on average historically risen by 90.1% based on the past 4 years of stock performance.
-
Candel Therapeutics, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is Candel Therapeutics, Inc. Stock Undervalued?The current Candel Therapeutics, Inc. [CADL] share price is $5.25. The Score for CADL is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
CADL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Candel Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Candel Therapeutics, Inc. has on average historically risen by 90.1% based on the past 4 years of stock performance.
Candel Therapeutics, Inc. Stock Rating
Sell
11
Candel Therapeutics, Inc. (CADL)
is a Sell
Is Candel Therapeutics, Inc. overpriced?
-
Candel Therapeutics, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
Candel Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
candeltx.com
52-Week Data
52-Week High:
9.13
52-Week Low:
4.25
Prediction Charts
Market Cap:
288.2M
Price in USD:
5.25
Volume:
2.1M
Beta:
-0.95
Technical Analysis
SMA50:
5.73
SMA100:
5.51
SMA200:
5.57
52-Wk Change:
-38.95%
Stock Predictions
-
Is Candel Therapeutics, Inc. stock public?Yes, Candel Therapeutics, Inc. is a publicly traded company.
-
What is the Candel Therapeutics, Inc. stock quote today?The Candel Therapeutics, Inc. stock price is 5.25 USD today.
-
How to buy Candel Therapeutics, Inc. stock online?You can buy Candel Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-9 | 5.83 | 5.77 | 5.83 | 5.53 |
| Feb-10 | 5.73 | 5.76 | 5.99 | 5.64 |
| Feb-11 | 5.78 | 5.53 | 5.82 | 5.40 |
| Feb-12 | 5.54 | 5.60 | 5.91 | 5.50 |
| Feb-13 | 5.66 | 5.68 | 5.82 | 5.61 |
| Feb-17 | 5.68 | 5.63 | 5.74 | 5.53 |
| Feb-18 | 5.66 | 5.85 | 5.99 | 5.57 |
| Feb-19 | 5.77 | 5.95 | 6.00 | 5.72 |
| Feb-20 | 5.45 | 5.11 | 5.50 | 4.98 |
| Feb-23 | 5.05 | 4.97 | 5.07 | 4.83 |
| Feb-24 | 4.95 | 5.09 | 5.11 | 4.76 |
| Feb-25 | 5.15 | 5.18 | 5.23 | 5.12 |
| Feb-26 | 5.18 | 5.15 | 5.20 | 5.04 |
| Feb-27 | 5.54 | 5.25 | 5.54 | 5.20 |
Candel Therapeutics, Inc. Earnings
Candel Therapeutics, Inc. Earnings Report: Per Share Candel Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Candel Therapeutics, Inc. Forecast Revenue Growth
Candel Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Candel Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.00 per share.
* Candel Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.